Related references
Note: Only part of the references are listed.Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
David M. G. Halpin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives
Evgeny N. Imyanitov et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)
Interobserver Reliability of Programmed Cell Death Ligand-1 Scoring Using the VENTANA PD-L1 (SP263) Assay in NSCLC
Gareth H. Williams et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Chronic Obstructive Pulmonary Disease
Wassim W. Labaki et al.
ANNALS OF INTERNAL MEDICINE (2020)
Prevalence of PRKDC mutations and association with response to immune checkpoint inhibitors in solid tumors
Yu Chen et al.
MOLECULAR ONCOLOGY (2020)
MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan-cancer
Yue Yang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
EPHA5 mutations predict survival after immunotherapy in lung adenocarcinoma
Zhiming Chen et al.
Aging-US (2020)
EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma
Hua Bai et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy
Minehiko Inomata et al.
DIAGNOSTICS (2020)
The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors
Ying Jin et al.
MOLECULAR CANCER (2020)
Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease
Sun Hye Shin et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC
D. Ross Camidge et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Somatic mutations of PREX2 gene in patients with hepatocellular carcinoma
Ming-Hui Yang et al.
SCIENTIFIC REPORTS (2019)
Airway inflammation in COPD: progress to precision medicine
Christopher Brightling et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Molecular links between COPD and lung cancer: new targets for drug discovery?
Gaetano Caramori et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades
Hao Chen et al.
FRONTIERS IN IMMUNOLOGY (2019)
Presence of Chronic Obstructive Pulmonary Disease (COPD) Impair Survival in Lung Cancer Patients Receiving Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI): A Nationwide, Population-Based Cohort Study
Chia-Che Wu et al.
JOURNAL OF CLINICAL MEDICINE (2019)
The immune landscape of esophageal cancer
Tu-Xiong Huang et al.
CANCER COMMUNICATIONS (2019)
Comparative analysis of whole-genome sequencing pipelines to minimize false negative findings
Kyu-Baek Hwang et al.
SCIENTIFIC REPORTS (2019)
Predictive value of a series of inflammatory markers in COPD for lung cancer diagnosis: a case-control study
Cecilia Mouronte-Roibas et al.
RESPIRATORY RESEARCH (2019)
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
Ferdinandos Skoulidis et al.
NATURE REVIEWS CANCER (2019)
Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade
Jerome Biton et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
fastp: an ultra-fast all-in-one FASTQ preprocessor
Shifu Chen et al.
BIOINFORMATICS (2018)
Multi-omic molecular profiling of lung cancer in COPD
Brian J. Sandri et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Understanding lymphocyte metabolism for use in cancer immunotherapy
Sarah MacPherson et al.
FEBS JOURNAL (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
COPD Guidelines: A Review of the 2018 GOLD Report
Shireen Mirza et al.
MAYO CLINIC PROCEEDINGS (2018)
Chronic obstructive pulmonary disease (COPD) and lung cancer screening
Robert P. Young et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2018)
PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort
Kenji Sawa et al.
LUNG CANCER (2017)
Mutations in TP53, PIK3CA, PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomes
Paul A. VanderLaan et al.
LUNG CANCER (2017)
InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines
Quan Li et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
Impact of COPD and emphysema on survival of patients with lung cancer: A meta-analysis of observational studies
Yong-hua Gao et al.
RESPIROLOGY (2016)
VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research
Zhongwu Lai et al.
NUCLEIC ACIDS RESEARCH (2016)
CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing
Eric Talevich et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution
Aaron M. Newman et al.
BIOINFORMATICS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Mechanistic links between COPD and lung cancer
A. McGarry Houghton
NATURE REVIEWS CANCER (2013)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Share Paper
